133 related articles for article (PubMed ID: 3553060)
1. In vitro and in vivo susceptibility of Candida keratitis to topical polyenes.
O'Day DM; Ray WA; Robinson RD; Head WS; Savage AM
Invest Ophthalmol Vis Sci; 1987 May; 28(5):874-80. PubMed ID: 3553060
[TBL] [Abstract][Full Text] [Related]
2. Correlation of in vitro and in vivo susceptibility of Candida albicans to amphotericin B and natamycin.
O'Day DM; Ray WA; Robinson RD; Head WS
Invest Ophthalmol Vis Sci; 1987 Mar; 28(3):596-603. PubMed ID: 3549613
[TBL] [Abstract][Full Text] [Related]
3. Differences in response in vivo to amphotericin B among Candida albicans strains.
O'Day DM; Ray WA; Robinson RD; Head WS; Williams TE
Invest Ophthalmol Vis Sci; 1991 Apr; 32(5):1569-72. PubMed ID: 2016138
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of antifungal agents in the cornea. II. Influence of corticosteroids.
O'Day DM; Ray WA; Robinson R; Head WS
Invest Ophthalmol Vis Sci; 1984 Mar; 25(3):331-5. PubMed ID: 6321389
[TBL] [Abstract][Full Text] [Related]
5. The influence of yeast growth phase in vivo on the efficacy of topical polyenes.
O'Day DM; Ray WA; Robinson RD; Head WS; Savage AM
Curr Eye Res; 1987 Feb; 6(2):363-8. PubMed ID: 3552454
[TBL] [Abstract][Full Text] [Related]
6. Influence of the corneal epithelium on the efficacy of topical antifungal agents.
O'Day DM; Ray WA; Head WS; Robinson RD
Invest Ophthalmol Vis Sci; 1984 Jul; 25(7):855-9. PubMed ID: 6329991
[TBL] [Abstract][Full Text] [Related]
7. Tolerance to amphotericin B in clinical isolates of Candida tropicalis.
Barchiesi F; Maracci M; Baldassarri I; Spreghini E; Giannini D; Scalise G
Diagn Microbiol Infect Dis; 2004 Nov; 50(3):179-85. PubMed ID: 15541603
[TBL] [Abstract][Full Text] [Related]
8. [Natamycin (pimaricin) in the treatment of experimental keratomycosis].
Behrens-Baumann W; Klinge B
Fortschr Ophthalmol; 1990; 87(3):237-40. PubMed ID: 2376371
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility to 5-fluorocytosine, miconazole and amphotericin B of Candida albicans strains isolated from the throat of non-AIDS patients.
Paniagua GL; Monroy E; Negrete E; Vaca S
Rev Latinoam Microbiol; 2002; 44(2):65-8. PubMed ID: 17063773
[TBL] [Abstract][Full Text] [Related]
10. [Chemotherapy of vaginal trichomoniasis and candidiasis in mice].
Wildfeuer A
Arzneimittelforschung; 1974 Jun; 24(6):937-43. PubMed ID: 4603387
[No Abstract] [Full Text] [Related]
11. Efficacy of antifungal agents in the cornea. IV. Amphotericin B methyl ester.
O'Day DM; Ray WA; Head WS; Robinson RD
Invest Ophthalmol Vis Sci; 1984 Jul; 25(7):851-4. PubMed ID: 6735649
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the inhibitory effect of voriconazole on the fungicidal activity of amphotericin B against Candida albicans in an in vitro kinetic model.
Lignell A; Löwdin E; Cars O; Sjölin J
J Antimicrob Chemother; 2008 Jul; 62(1):142-8. PubMed ID: 18408237
[TBL] [Abstract][Full Text] [Related]
13. Topical caspofungin for treatment of keratitis caused by Candida albicans in a rabbit model.
Goldblum D; Frueh BE; Sarra GM; Katsoulis K; Zimmerli S
Antimicrob Agents Chemother; 2005 Apr; 49(4):1359-63. PubMed ID: 15793112
[TBL] [Abstract][Full Text] [Related]
14. Effects of amphotericin B incorporated into liposomes and in lipid suspensions in the treatment of murine candidiasis.
Kretschmar M; Nichterlein T; Hannak D; Hof H
Arzneimittelforschung; 1996 Jul; 46(7):711-5. PubMed ID: 8842344
[TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system.
Groll AH; Giri N; Petraitis V; Petraitiene R; Candelario M; Bacher JS; Piscitelli SC; Walsh TJ
J Infect Dis; 2000 Jul; 182(1):274-82. PubMed ID: 10882607
[TBL] [Abstract][Full Text] [Related]
16. In vitro evaluation of combination antifungal activity against Fusarium species isolated from ocular tissues of keratomycosis patients.
Li L; Wang Z; Li R; Luo S; Sun X
Am J Ophthalmol; 2008 Nov; 146(5):724-8. PubMed ID: 18707669
[TBL] [Abstract][Full Text] [Related]
17. [Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates].
Oz Y; Akşit F; Kiraz N; Kiremitçi A
Mikrobiyol Bul; 2008 Jan; 42(1):149-55. PubMed ID: 18444574
[TBL] [Abstract][Full Text] [Related]
18. High purity amphotericin B.
Cleary JD; Chapman SW; Swiatlo E; Kramer R
J Antimicrob Chemother; 2007 Dec; 60(6):1331-40. PubMed ID: 17921178
[TBL] [Abstract][Full Text] [Related]
19. [Experimental studies of local therapy of Candida keratomycosis with amphotericin B].
Behrens-Baumann W; Uter W; Ansorg R
Klin Monbl Augenheilkd; 1987 Aug; 191(2):125-8. PubMed ID: 3669506
[TBL] [Abstract][Full Text] [Related]
20. [Biofilm production and antifungal susceptibility patterns of Candida species].
Yücesoy M; Karaman M
Mikrobiyol Bul; 2004; 38(1-2):91-8. PubMed ID: 15293907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
